Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1981 1
1982 1
1985 4
1986 1
1987 1
1993 3
1995 1
1997 1
1998 1
1999 1
2002 1
2003 1
2004 2
2007 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Acute cecitis.
Sklenar I, Kurz H, Byrne MP. Sklenar I, et al. IMJ Ill Med J. 1981 Feb;159(2):102-3. IMJ Ill Med J. 1981. PMID: 6110647 No abstract available.
Phase I and pharmacokinetic study of the polyamine synthesis inhibitor SAM486A in combination with 5-fluorouracil/leucovorin in metastatic colorectal cancer.
van Zuylen L, Bridgewater J, Sparreboom A, Eskens FA, de Bruijn P, Sklenar I, Planting AS, Choi L, Bootle D, Mueller C, Ledermann JA, Verweij J. van Zuylen L, et al. Among authors: sklenar i. Clin Cancer Res. 2004 Mar 15;10(6):1949-55. doi: 10.1158/1078-0432.ccr-02-0995. Clin Cancer Res. 2004. PMID: 15041711 Free article. Clinical Trial.
Clinical efficacy, tolerability, and safety of SAM486A, a novel polyamine biosynthesis inhibitor, in patients with relapsed or refractory non-Hodgkin's lymphoma: results from a phase II multicenter study.
Pless M, Belhadj K, Menssen HD, Kern W, Coiffier B, Wolf J, Herrmann R, Thiel E, Bootle D, Sklenar I, Müller C, Choi L, Porter C, Capdeville R. Pless M, et al. Among authors: sklenar i. Clin Cancer Res. 2004 Feb 15;10(4):1299-305. doi: 10.1158/1078-0432.ccr-0977-03. Clin Cancer Res. 2004. PMID: 14977828 Clinical Trial.
A phase I and pharmacokinetic study of SAM486A, a novel polyamine biosynthesis inhibitor, administered on a daily-times-five every-three-week schedule in patients with Advanced solid malignancies.
Siu LL, Rowinsky EK, Hammond LA, Weiss GR, Hidalgo M, Clark GM, Moczygemba J, Choi L, Linnartz R, Barbet NC, Sklenar IT, Capdeville R, Gan G, Porter CW, Von Hoff DD, Eckhardt SG. Siu LL, et al. Among authors: sklenar it. Clin Cancer Res. 2002 Jul;8(7):2157-66. Clin Cancer Res. 2002. PMID: 12114416 Clinical Trial.
Phase III efficacy study of interleukin-3 after autologous bone marrow transplantation in patients with malignant lymphoma.
Brouwer RE, Vellenga E, Zwinderman KH, Bezwoda WR, Durrant ST, Herrmann RP, Kiese B, Maraninchi D, Milligan DW, Sklenar I, Tabilio A, Volonte JL, Winfield DA, Fibbe WE. Brouwer RE, et al. Among authors: sklenar i. Br J Haematol. 1999 Sep;106(3):730-6. doi: 10.1046/j.1365-2141.1999.01609.x. Br J Haematol. 1999. PMID: 10468866 Free article. Clinical Trial.
21 results